Literature DB >> 22574854

Diagnosis and inflammatory response of patients with candiduria.

S Helbig1, J M Achkar, N Jain, X Wang, P Gialanella, M Levi, B C Fries.   

Abstract

Candiduria is common in hospitalised patients, but the clinical relevance is still unclear. This study was done to further our knowledge on detection of and host responses to candiduria. Urines and clinical data from 136 patients in whom presence of yeast was diagnosed by microscopic urinalysis were collected. Diagnosis by standard urine culture methods on blood and MacConkey agar as well as on fungal culture medium (Sabouraud dextrose agar) was compared. Inflammatory parameters (IL-6 and IL-17, Ig) were quantified in the urine and compared with levels in control patients without candiduria. Standard urine culture methods detected only 37% of Candida spp. in urine. Sensitivity was especially low (23%) for C. glabrata and was independent of fungal burden. Candida specific IgG but not IgA was significantly elevated when compared with control patients (P < 0.0001 and 0.07 respectively). In addition, urine levels of IL-6 and IL-17 were significantly higher in candiduric patients when compared with control patients (P < 0.001). Multivariate analysis documented an independent association between an increased IgG (odds ratio (OR) 136.0, 95% confidence interval (CI) 25.7-719.2; P < 0.0001), an increased IL-17 (OR 17.4, 95% CI 5.3-57.0; P < 0.0001) and an increased IL-6 level (OR 4.9, 95% CI 1.9-12.4; P = 0.001) and candiduria. In summary, our data indicate that clinical studies on candiduria should include fungal urine culture and that inflammatory parameters may be helpful to identify patients with clinically relevant candiduria.
© 2012 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22574854      PMCID: PMC3419311          DOI: 10.1111/j.1439-0507.2012.02201.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  40 in total

1.  Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli.

Authors:  Indira U Mysorekar; Matthew A Mulvey; Scott J Hultgren; Jeffrey I Gordon
Journal:  J Biol Chem       Date:  2001-12-13       Impact factor: 5.157

2.  Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group.

Authors:  J D Sobel; C A Kauffman; D McKinsey; M Zervos; J A Vazquez; A W Karchmer; J Lee; C Thomas; H Panzer; W E Dismukes
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

3.  Speciation and densities of yeasts in human urine specimens.

Authors:  D G Ahearn; J R Jannach; F J Roth
Journal:  Sabouraudia       Date:  1966-10

4.  Nosocomial infections in combined medical-surgical intensive care units in the United States.

Authors:  M J Richards; J R Edwards; D H Culver; R P Gaynes
Journal:  Infect Control Hosp Epidemiol       Date:  2000-08       Impact factor: 3.254

5.  Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.

Authors:  Weitao Huang; Li Na; Paul L Fidel; Paul Schwarzenberger
Journal:  J Infect Dis       Date:  2004-06-22       Impact factor: 5.226

6.  Burden of hospitalization of patients with Candida and Aspergillus infections in Australia.

Authors:  Monica Slavin; John Fastenau; Isaya Sukarom; Panagiotis Mavros; Steven Crowley; William C Gerth
Journal:  Int J Infect Dis       Date:  2004-03       Impact factor: 3.623

7.  Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections.

Authors:  Julian R Naglik; Catherine A Rodgers; Penelope J Shirlaw; Jennifer L Dobbie; Lynette L Fernandes-Naglik; Deborah Greenspan; Nina Agabian; Stephen J Challacombe
Journal:  J Infect Dis       Date:  2003-07-14       Impact factor: 5.226

8.  Candiduria in critically ill patients admitted to intensive care medical units.

Authors:  Francisco Alvarez-Lerma; Juan Nolla-Salas; Cristobal León; Mercedes Palomar; Ricard Jordá; Nieves Carrasco; Felipe Bobillo
Journal:  Intensive Care Med       Date:  2003-05-16       Impact factor: 17.440

9.  Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria.

Authors:  S Hedges; P Anderson; G Lidin-Janson; P de Man; C Svanborg
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

10.  Interleukin-6 induced at mucosal surfaces by gram-negative bacterial infection.

Authors:  P de Man; C van Kooten; L Aarden; I Engberg; H Linder; C Svanborg Edén
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

View more
  5 in total

1.  Rat indwelling urinary catheter model of Candida albicans biofilm infection.

Authors:  Jeniel E Nett; Erin G Brooks; Jonathan Cabezas-Olcoz; Hiram Sanchez; Robert Zarnowski; Karen Marchillo; David R Andes
Journal:  Infect Immun       Date:  2014-09-02       Impact factor: 3.441

2.  [Candiduria! What now? : Therapy of urinary tract infections with Candida].

Authors:  H Hof
Journal:  Urologe A       Date:  2017-02       Impact factor: 0.639

Review 3.  Fungal infections diagnosis - Past, present and future.

Authors:  Alexandre Mendonça; Helena Santos; Ricardo Franco-Duarte; Paula Sampaio
Journal:  Res Microbiol       Date:  2021-12-01       Impact factor: 3.946

Review 4.  Urinary tract infections and Candida albicans.

Authors:  Payam Behzadi; Elham Behzadi; Reza Ranjbar
Journal:  Cent European J Urol       Date:  2015-03-13

Review 5.  A New Gold Rush: A Review of Current and Developing Diagnostic Tools for Urinary Tract Infections.

Authors:  Raymond Xu; Nicholas Deebel; Randy Casals; Rahul Dutta; Majid Mirzazadeh
Journal:  Diagnostics (Basel)       Date:  2021-03-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.